The Research & Development team at Vaccitech focuses on advancing the company's proprietary T cell immunotherapy platform. This involves designing and developing viral vectors, optimizing RNA discovery, ensuring robust manufacturing processes, and conducting comprehensive analytical and synthetic immunotherapy research. Their work aims to create effective therapies and vaccines for cancer and infectious diseases.
View all